The
gut
microbiota
and
its
homeostasis
play
a
crucial
role
in
human
health.
However,
for
some
diseases
related
to
the
microbiota,
current
traditional
medicines
can
only
relieve
symptoms,
it
is
difficult
solve
root
causes
or
even
cause
side
effects
like
disturbances
microbiota.
Increasing
clinical
studies
evidences
have
demonstrated
that
probiotics,
prebiotics,
postbiotics
prevent
treat
various
diseases,
but
currently
they
be
used
as
dietary
supplements
rather
than
medicines,
which
restricts
application
of
probiotics
field
medicine.
Here,
this
review
analyzes
importance
health
problems
systematically
summarizes
effectiveness
mechanisms
maintaining
treating
based
on
animal
models
trials.
And
research
outcomes
development
trends
field,
challenges
prospects
their
health,
alleviating
are
analyzed.
It
hoped
promote
disease
treatment
open
up
new
frontiers
probiotic
research.
Nutrients,
Год журнала:
2021,
Номер
13(2), С. 699 - 699
Опубликована: Фев. 22, 2021
The
most
prevalent
diseases
of
our
time,
non-communicable
(NCDs)
(including
obesity,
type
2
diabetes,
cardiovascular
and
some
types
cancer)
are
rising
worldwide.
All
them
share
the
condition
an
“inflammatory
disorder”,
with
impaired
immune
functions
frequently
caused
or
accompanied
by
alterations
in
gut
microbiota.
These
multifactorial
maladies
also
have
common
malnutrition
related
to
physiopathology.
In
this
context,
diet
is
greatest
modulator
system–microbiota
crosstalk,
much
interest,
new
challenges,
arising
area
precision
nutrition
as
a
way
towards
treatment
prevention.
It
fact
that
westernized
(WD)
partly
responsible
for
increased
prevalence
NCDs,
negatively
affecting
both
microbiota
system.
Conversely,
other
nutritional
approaches,
such
Mediterranean
(MD),
positively
influence
system
microbiota,
proposed
not
only
potential
tool
clinical
management
different
disease
conditions,
but
prevention
health
promotion
globally.
Thus,
purpose
review
determine
regulatory
role
components
WD
MD
interplay,
order
understand,
create
awareness
of,
over
key
components.
International Journal of Molecular Sciences,
Год журнала:
2020,
Номер
21(17), С. 6402 - 6402
Опубликована: Сен. 3, 2020
Constant
remodeling
of
tight
junctions
to
regulate
trans-epithelial
permeability
is
essential
in
maintaining
intestinal
barrier
functions
and
thus
preventing
diffusion
small
molecules
bacteria
host
systemic
circulation.
Gut
microbiota
dysbiosis
dysfunctional
gut
have
been
correlated
a
large
number
diseases
such
as
obesity,
type
2
diabetes
inflammatory
bowel
disease.
This
led
the
hypothesis
that
bacteria-epithelial
cell
interactions
are
key
regulators
epithelial
through
modulation
junctions.
Nevertheless,
molecular
basis
host-pathogen
remains
unclear
mostly
due
inability
most
vitro
models
recreate
differentiated
tissue
structure
components
observed
normal
epithelium.
Recent
advances
development
novel
cellular
model
derived
from
stem
cells,
so-called
organoids,
encompassing
all
types
reproducing
physiological
properties
tissue.
We
summarize
herein
knowledge
on
aspects
involvement
interactions.
review
also
focuses
organoids
promising
for
study
microbiota-host
interaction.
Gut Microbes,
Год журнала:
2019,
Номер
11(3), С. 285 - 304
Опубликована: Март 26, 2019
The
gastrointestinal
microbiome
plays
a
pivotal
role
in
physiological
homeostasis
of
the
intestine
as
well
pathophysiology
diseases
including
inflammatory
bowel
(IBD)
and
colorectal
cancer
(CRC).
Emerging
evidence
suggests
that
gut
microbiota
signal
to
mitochondria
mucosal
cells,
epithelial
cells
immune
cells.
Gut
signaling
has
been
shown
alter
mitochondrial
metabolism,
activate
induce
inflammasome
signaling,
barrier
function.
Both
dysbiosis
dysfunction
are
associated
with
chronic
intestinal
inflammation
CRC.
This
review
discusses
metabolism
dysfunction,
known
microbiota-mediated
alterations
during
IBD
Journal of Digestive Diseases,
Год журнала:
2020,
Номер
21(3), С. 147 - 159
Опубликована: Фев. 10, 2020
Gut
microbiota
constitute
the
largest
reservoir
of
human
microbiome
and
are
an
abundant
stable
ecosystem-based
on
its
diversity,
complexity,
redundancy,
host
interactions
This
ecosystem
is
indispensable
for
development
health.
The
integrity
intestinal
mucosal
barrier
depends
with
gut
microbiota.
commensal
bacterial
community
implicated
in
pathogenesis
inflammatory
bowel
disease
(IBD),
including
ulcerative
colitis
(UC).
dysbiosis
microbes
characterized
by
reduced
biodiversity,
abnormal
composition
microbiota,
altered
spatial
distribution,
as
well
among
between
different
strains
host.
defects
microecology,
related
metabolic
pathways
molecular
mechanisms,
play
a
critical
role
innate
immunity
mucosa
UC.
Fecal
transplantation
(FMT)
has
been
used
to
treat
many
diseases
most
promising
outcome
reported
antibiotic-associated
diarrhea,
followed
IBD.
review
evaluated
results
various
reports
FMT
efficacy
remains
highly
controversial,
needs
be
regularized
integrated
management,
standardization
procedures,
individualization
treatment.
World Journal of Gastroenterology,
Год журнала:
2022,
Номер
28(30), С. 4053 - 4060
Опубликована: Авг. 9, 2022
The
gut
microbiota
is
a
complex
community
of
microorganisms
that
inhabit
the
digestive
tracts
humans,
living
in
symbiosis
with
host.
Dysbiosis,
characterized
by
an
imbalance
between
beneficial
and
opportunistic
microbiota,
associated
several
gastrointestinal
disorders,
such
as
irritable
bowel
syndrome
(IBS);
inflammatory
disease
(IBD),
represented
ulcerative
colitis
Crohn's
disease;
colorectal
cancer
(CRC).
Dysbiosis
can
disrupt
mucosal
barrier,
resulting
perpetuation
inflammation
carcinogenesis.
increase
some
specific
groups
harmful
bacteria,
Escherichia
coli
(E.
coli)
enterotoxigenic
Bacteroides
fragilis
(ETBF),
has
been
chronic
tissue
release
pro-inflammatory
carcinogenic
mediators,
increasing
chance
developing
CRC,
following
inflammation-dysplasia-cancer
sequence
IBD
patients.
Therefore,
aim
present
review
was
to
analyze
correlation
changes
development
maintenance
IBD,
IBD-associated
CRC.
Patients
CRC
have
shown
reduced
bacterial
diversity
abundance
compared
healthy
individuals,
enrichment
Firmicute
sand
Bacteroidetes.
Specific
bacteria
are
also
onset
progression
Fusobacterium
nucleatum,
E.
coli,
Enterococcus
faecalis,
Streptococcus
gallolyticus,
ETBF.
Future
research
evaluate
advantages
modulating
preventive
measures
high-risk
patients,
directly
affecting
prognosis
quality
life
Journal of Lipid Research,
Год журнала:
2018,
Номер
60(2), С. 323 - 332
Опубликована: Ноя. 29, 2018
Recently,
the
gut
microbiota
has
emerged
as
a
crucial
factor
that
influences
cholesterol
metabolism.
Ever
since,
significant
interest
been
shown
in
investigating
these
host-microbiome
interactions
to
uncover
microbiome-mediated
functions
on
and
bile
acid
(BA)
Indeed,
changes
composition
and,
hence,
its
derived
metabolites
have
previously
reported
subsequently
impact
metabolic
processes
linked
several
diseases.
In
this
context,
associations
between
disrupted
microbiome,
impaired
BA
metabolism,
dysregulation
highlighted.
Extensive
advances
metagenomic
metabolomic
studies
field
allowed
us
further
our
understanding
of
role
intestinal
bacteria
health
disease.
However,
only
few
provided
mechanistic
insights
into
their
Identifying
myriad
maintain
homeostasis
remain
an
important
challenge
such
research.
review,
we
discuss
association
with
disease
settings,
potential
modulating
promising
therapeutic
target
lower
hypercholesterolemia.
Objective
The
microbiome
contributes
to
the
pathogenesis
of
inflammatory
bowel
disease
(IBD)
but
relative
contribution
different
lifestyle
and
environmental
factors
compositional
variability
gut
microbiota
is
unclear.
Design
Here,
we
rank
size
effect
activity,
medications,
diet
geographic
location
faecal
composition
(16S
rRNA
gene
sequencing)
in
patients
with
Crohn’s
(CD;
n=303),
ulcerative
colitis
(UC;
n
=
228)
controls
(n=161),
followed
longitudinally
(at
three
time
points
16
weeks
intervals).
Results
Reduced
diversity
increased
was
confirmed
CD
UC
compared
controls.
Significant
differences
between
diseases,
particularly
CD,
were
evident.
Longitudinal
analyses
revealed
reduced
temporal
stability
IBD,
changes
activity.
Machine
learning
separated
from
controls,
active
inactive
disease,
when
consecutive
modelled.
Geographic
accounted
for
most
variance,
second
presence
or
absence
by
history
surgical
resection,
alcohol
consumption
diagnosis,
medications
(90.3%)
variance
stochastic
unexplained.
Conclusion
popular
concept
precision
medicine
rational
design
any
therapeutic
manipulation
will
have
contend
not
only
heterogeneity
host
response,
also
widely
differing
lifestyles
much
still
unaccounted
for.
Frontiers in Microbiology,
Год журнала:
2019,
Номер
10
Опубликована: Июль 17, 2019
An
imbalance
in
the
bacterial
species
resulting
loss
of
intestinal
homeostasis
has
been
described
inflammatory
bowel
diseases
(IBD)
and
irritable
syndrome
(IBS).
In
this
prospective
study,
we
investigated
whether
IBD
IBS
patients
exhibit
specific
changes
richness
distribution
fecal
mucosal-associated
microbiota.
Additionally,
assessed
potential
16S
rRNA
gene
amplicons
biomarkers
for
IBD,
IBS,
controls
(CTRLs)
by
comparison
taxonomic
composition.
The
relative
abundance
bacteria,
at
phylum
genus/species
levels,
diversity
were
determined
through
sequence-based
mucosal
microbiota
analysis.
Linear
discriminant
analysis
effect
size
(LEfSe)
was
used
biomarker
discovery
associated
to
as
compared
CTRLs.
samples,
characterized
a
microbial
reduction,
going
from
CTRLs
IBD.
β-diversity
showed
clear
separation
between
with
no
significant
mucosa
stool
samples
all
groups.
there
difference
inflamed
not
mucosa.
Based
upon
LEfSe
data,
Anaerostipes
Ruminococcaceae
identified
most
differentially
abundant
taxa
Erysipelotrichi
while
Gammaproteobacteria,
Enterococcus,
Enterococcaceae
This
study
provides
an
overview
alterations
may
aid
identifying
IBS.
Journal of Biomedical Science,
Год журнала:
2019,
Номер
26(1)
Опубликована: Янв. 3, 2019
Gut
microbiota
interacting
with
an
intact
mucosal
surface
are
key
to
the
maintenance
of
homeostasis
and
health.
This
review
discusses
current
state
knowledge
biofilm
mode
growth
these
communities,
how
in
turn
their
disruptions
may
cause
disease.
Beyond
alterations
relative
microbial
abundance
diversity,
aim
is
focus
on
structure
function,
dispersion
commensal
bacteria,
mechanisms
whereby
dispersed
commensals
become
pathobionts.
Recent
findings
have
linked
iron
acquisition
expression
virulence
factors
gut
that
Causal
studies
emerging,
common
enteropathogen-induced
disruptions,
as
well
those
reported
for
Inflammatory
Bowel
Disease
colo-rectal
cancer
used
examples
illustrate
great
translational
potential
such
research.
These
new
observations
shed
light
our
attempts
develop
therapies
able
protect
restore
many
disease
conditions
been
dysbiosis.